ImmuPharma (25I) Revenue

0 Followers

ImmuPharma Revenue

ImmuPharma had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, ImmuPharma had annual revenue of 0.00 with ― growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

€0

Employees

Market Cap

€25.38M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	―	―	―
Dec 31, 2024	―	―	―
Dec 31, 2023	―	―	―
Dec 31, 2022	―	-118.35K	-100.00%
Dec 31, 2021	118.35K	-8.32K	-6.57%
Dec 31, 2020	126.67K	48.74K	+62.55%
Dec 31, 2019	77.92K	-3.36K	-4.13%
Dec 31, 2018	81.28K	-69.18K	-45.98%
Dec 31, 2017	150.46K	―	―